College of Pharmacy
In this section
Podcast Archive
In this section
HelixTalk Episode #111 - The Basics of Immune Checkpoint Inhibitors for Non-Oncology Healthcare Providers
Date posted: April 7, 2020, 6:00 am
In this episode, we chat with Eris Tollkuci, PharmD, BCOP regarding what every non-onc healthcare provider should know about immune checkpoint inhibitors (specifically PD-1/PD-L1 inhibitors) in patients with cancer.
HelixTalk Episode #110 - Top 10 Updated Recommendations from the ADA Standards of Care 2020
Date posted: March 17, 2020, 6:00 am
In this episode, we summarize some of the most significant changes in the newest version of American Diabetes Association - 2020 Standards of Medical Care in Diabetes guidelines.
HelixTalk Episode #109 - Clinical Controversy: Can Obese Patients Take DOACs for Acute VTE?
Date posted: February 25, 2020, 6:00 am
In this episode, we review the pros, cons, and literature regarding the use of DOACs versus warfarin in obese patients with venous thromboembolism.
HelixTalk Episode #108 - 6 Reasons to be Addicted to Lifestyle Medicine
Date posted: February 4, 2020, 6:00 am
In this episode, we provide an overview of lifestyle medicine, its six pillars, and how it plays a role in improving health outcomes.
HelixTalk Episode #107 - You’re Going to Go Bananas Over this Brief Review of Hyperkalemia
Date posted: January 14, 2020, 6:00 am
In this episode, we discuss clinical pearls and management related to chronic and acute hyperkalemia.
HelixTalk Episode #106 - It’s Finally Here! The 2019 IDSA CAP Guidelines
Date posted: December 24, 2019, 6:00 am
In this episode, we discuss the important updates in the 2019 IDSA Community Acquired Pneumonia (CAP) guidelines with Dr. Christie Bertram, PharmD, an Infectious Diseases Clinical Pharmacist and Assistant Professor at Rosalind Franklin University’s College of Pharmacy.
HelixTalk Episode #105 - Unraveling the Mystery of P2Y12 Inhibitors: Clinical Pearls and Comparative Evidence
Date posted: December 3, 2019, 6:00 am
In this episode, we review the three oral P2Y12 inhibitors on the market (clopidogrel, prasugrel, ticagrelor) and discuss each agent’s clinical pearls, comparative effectiveness, and unique precautions.
HelixTalk Episode #104 - Breathtaking Updates from Global INitiative for Asthma (GINA) Guidelines 2019
Date posted: November 12, 2019, 6:00 am
In this episode, we will discuss what is the latest and greatest from the GINA (Global INitiative for Asthma) 2019 guidelines, including new recommendations regarding rescue inhalers, tiotropium, and azithromycin for asthma.
HelixTalk Episode #103 - How Can Peeing Sugar Improve Heart Failure? No One Knows, but We Know It Works!
Date posted: October 22, 2019, 6:00 am
In this episode, we discuss the newly published DAPA-HF trial, which studied dapagliflozin (a drug for diabetes) among patients who had heart failure with reduced ejection fraction (HFrEF) many of which did NOT have a history of diabetes.
HelixTalk Episode #102 - When the Squatty Potty Isn’t Enough: Drug Therapy for Chronic Idiopathic Constipation
Date posted: October 1, 2019, 6:00 am
In this episode, we provide an overview of chronic idiopathic constipation and discuss available treatment options with a particular focus on lubiprostone, linaclotide, plecanatide, and prucalopride.